Coforge Eyes $5 Billion Revenue by FY30; Analysts Predict 50% Upside

IT major Coforge has set an ambitious growth trajectory, targeting a revenue milestone of $5 billion by fiscal year 2030. This bold guidance, shared during its recent investor day, has sparked significant interest among market analysts who see massive potential in the company's strategic pivot toward AI-led services.

Ambitious Growth Targets and Revenue Roadmap

Coforge’s management has outlined a clear roadmap to reach the $5 billion mark by FY30. To achieve this, the company is projecting a revenue Compound Annual Growth Rate (CAGR) of approximately 19% between FY26 and FY30. A significant portion of this expansion—nearly 15%—is expected to be driven by organic growth.

The company intends to fuel this momentum through deeper engagement with its existing key accounts, scaling strategic growth bets, and capitalizing on partner-led opportunities. Unlike many in the sector that view Generative AI as a potential disruptor, Coforge views it as a primary growth accelerator that is actively creating new demand pools across various service lines.

AI as a Core Differentiator: The 'Mod Squad' Model

A key driver behind the bullish outlook from brokerages like Nomura is Coforge’s deep integration of Artificial Intelligence into its delivery model. The firm has transitioned toward a "Forward Deployed Engineer" (FDE) approach and utilizes "Mod Squads"—a hybrid delivery model combining human expertise with AI agents.

Nomura has reiterated a 'Buy' rating with a target price of Rs 2,100, implying a 43.3% upside. The brokerage highlighted the "Coforge One AI" platform as a major differentiator. Furthermore, Nuvama has set an even higher target of Rs 2,200, suggesting a 50% upside, noting that over 75% of Coforge's AI pilots have successfully transitioned into full-scale production.

Robust Order Book and Vertical Expansion

The company's financial health is bolstered by a substantial order book, which has expanded to $1.75 billion—roughly 2.4 times its levels seen in FY22. Nuvama pointed out that the healthcare and public sector verticals are expected to provide strong support for large deal momentum, particularly leading into FY27.

Хоча JM Financial зберігає більш консервативну позицію з рекомендацією «Add» та цільовою ціною 1 600 рупій, компанія зазначила, що критично важливими будуть здатність покращити конверсію грошових потоків та успішна інтеграція придбання Encora. Керівництво вважає, що операції на базі ШІ можуть забезпечити зростання ефективності на 35–50%, що значно підвищить продуктивність і показники маржинальності.

Основні висновки